OBI Pharma Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Pembroke VCT PLC Announces Issue of Ordinary Shares
Pembroke VCT PLC announced that the Company has raised a total of GBP11.1 million under the Offer, including additional applications received in respect of the 2013/2014 tax year. An initial allotment of shares took place on April 5, 2013 in respect of 7,916,000 Ordinary Shares and a further allotment took place on April 8, 2013 in respect of 1,155,000 Ordinary Shares, both such allotments having been made pursuant to the Offer. The Offer price at which the Ordinary Shares were allotted was 100 pence per share. Dealings are expected to commence on or around April 16, 2013.
Latest Key Developments in Biotechnology
- Pfenex Inc announces closing of initial public offering
- Fate Therapeutics announces FDA clearance of IND for clinical development of Prohema in inherited metabolic disorders
- Covance Inc lowers high end of prior FY 2014 revenue outlook to a range in line with estimates; narrows FY 2014 EPS outlook to a range in line with estimates; reaffirms Q3, Q4 2014 EPS outlook
- Dyax Corp raises FY 2014 revenue outlook
- Share this
- Digg this